|
Market Closed -
Nasdaq
21:00:00 28/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 9.590 USD | -4.67% |
|
+52.46% | -66.77% |
| 08-24 | Capricor Therapeutics Shares Rise as FDA Extends Deramiocel Review | DJ |
| 08-24 | Capricor Therapeutics Says FDA Target Action Date for Deramiocel Extended by Three Months | MT |
| Market Cap | 558M 480M 450M 411M 775M 53.29B 777M 5.34B 2.09B 26.9B 2.09B 2.05B 89.19B | P/E 2026 * |
-4.2x | P/E 2027 * | -6x |
|---|---|---|---|---|---|
| Enterprise Value | 558M 480M 450M 411M 775M 53.29B 777M 5.34B 2.09B 26.9B 2.09B 2.05B 89.19B | EV / Sales 2026 * |
35.2x | EV / Sales 2027 * | 11.4x |
| Free-Float |
90.56% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript : Capricor Therapeutics, Inc.
| 1 day | -4.67% | ||
| 1 week | +52.46% | ||
| Current month | +149.09% | ||
| 1 month | +45.97% | ||
| 3 months | -67.99% | ||
| 6 months | -65.66% | ||
| Current year | -66.77% |
| 1 week | 6.34 |  | 10.61 |
| 1 month | 3.66 | | 10.61 |
| Current year | 2.96 | | 36.82 |
| 1 year | 2.96 | | 40.37 |
| 3 years | 2.68 | | 40.37 |
| 5 years | 2.56 | | 40.37 |
| 10 years | 0.88 | | 42.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Linda Marbán
CEO | Chief Executive Officer | 62 | 19/11/2013 |
Anthony Bergmann
DFI | Director of Finance/CFO | 40 | 31/12/2017 |
Michael Binks
CTO | Chief Tech/Sci/R&D Officer | - | 12/05/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Frank Litvack
CHM | Chairman | 70 | 31/10/2013 |
David Musket
BRD | Director/Board Member | 68 | 19/11/2013 |
George Dunbar
BRD | Director/Board Member | 79 | 19/11/2013 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 26/05/26 | Free | CHIEF COMMERCIAL OFFICER | 80,000 | 0.1383% | ||
| 18/05/26 | Fiscal year | Chief Financial Officer | 6,000 | 0.0104% | ||
| 13/05/26 | Fiscal year | Chairman | 7,874 | 0.0136% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.67% | +52.46% | +52.71% | +57.34% | 558M | |
| -1.59% | -3.35% | +52.37% | +93.70% | 69.54B | |
| -1.34% | -0.75% | +48.21% | +91.86% | 64.97B | |
| +0.30% | -0.69% | +52.56% | +10.23% | 26.51B | |
| -2.35% | -5.75% | -12.90% | +448.54% | 25.89B | |
| -8.37% | -12.43% | +2.08% | -16.71% | 25.64B | |
| -0.96% | +10.36% | +283.06% | +436.50% | 20.22B | |
| -0.51% | +0.23% | +35.77% | -18.70% | 19.98B | |
| -1.91% | -4.37% | +13.28% | +535.19% | 15.69B | |
| -1.47% | +0.68% | +45.51% | +143.08% | 13.49B | |
| Average | -2.29% | +2.98% | +57.26% | +178.10% | 28.25B | |
| Weighted average by Cap. | -1.94% | -1.41% | +53.73% | +151.32% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 15.82M 13.64M 12.79M 11.67M 21.99M 1.51B 22.06M 152M 59.18M 763M 59.41M 58.12M 2.53B | 48.89M 42.13M 39.5M 36.06M 67.92M 4.67B 68.14M 469M 183M 2.36B 184M 180M 7.82B |
| Net income | -132M -114M -107M -97.69M -184M -12.66B -185M -1.27B -495M -6.39B -497M -486M -21.19B | -95.89M -82.62M -77.47M -70.72M -133M -9.16B -134M -919M -359M -4.63B -360M -352M -15.34B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/08/26 | US$9.590 | -4.67% | 5,186,466 |
| 27/08/26 | US$10.06 | +7.48% | 12,045,617 |
| 26/08/26 | US$9.360 | +12.91% | 12,037,061 |
| 25/08/26 | US$8.290 | +21.91% | 17,634,423 |
| 24/08/26 | US$6.800 | +8.11% | 20,085,577 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CAPR Stock
Select your edition
All financial news and data tailored to specific country editions
